Cirugía General, Clinica Universidad de Navarra, España.
Cirugía General, Clínica Universidad de Navarra, España.
Rev Esp Enferm Dig. 2021 May;113(5):389. doi: 10.17235/reed.2021.7807/2021.
Apart from pulmonary manifestations, there is an increased incidence of pancreatic involvement and acute pancreatitis (AP) reported in COVID-19 patients. In January 2021, a PubMed search using the terms "Acute Pancreatitis, COVID-19" yielded a result including 94 studies. Most of the studies refer to isolated cases or limited series, with the added difficulty that some authors have considered AP as elevated lipase and/or amylase levels without the diagnostic criteria for AP being met, as highlighted by Chivato et al. in relation to the case they report. Pancreatic involvement has been reported in 17 % of COVID-19 patients and AP in 1.8-2.0 % of these patients.
除了肺部表现外，COVID-19 患者还会出现胰腺受累和急性胰腺炎（AP）的发病率增加。2021 年 1 月，使用术语“急性胰腺炎，COVID-19”在 PubMed 上进行搜索，结果包括 94 项研究。大多数研究涉及孤立病例或有限的系列，此外，一些作者认为 AP 是指脂肪酶和/或淀粉酶水平升高，而没有达到 AP 的诊断标准，Chivato 等人在报告他们的病例时就强调了这一点。COVID-19 患者中有 17%的患者胰腺受累，1.8-2.0%的患者出现 AP。
